ANXA2 and precursor B-cell acute lymphoblastic leukemia: Whether B-ALL progression was impaired in an ANXA2-deficient BMM, characterized by a denser ECM than in WT mice, due to entrapment of growth factors alone or, additionally, due to mechanical hindrance of B-ALL progression could not be completely clarified.